Documentation

Pre-session

E/CN.7/2021/1   

Provisional agenda, annotations and proposed organization of work

E/CN.7/2021/2-E/CN.15/2021/2

Report of the Executive Director on the activities of the United Nations Office on Drugs and Crime 

E/CN.7/2021/3-E/CN.15/2021/3

Note by the Secretariat on the work of the standing open-ended working group on improving the governance and financial situation of the United Nations Office on Drugs and Crime

E/CN.7/2021/4

Report of the Secretariat on the world situation with regard to drug abuse

E/CN.7/2021/5

Report of the Secretariat on the world situation with regard to drug trafficking

E/CN.7/2021/6 

Note by the Secretariat on promoting coordination and alignment of decisions between the Commission on Narcotic Drugs and the Programme Coordinating Board of the Joint United Nations Programme on HIV/AIDS

E/CN.7/2021/7

Report of the Secretariat on action by the subsidiary bodies of the Commission on Narcotic Drugs

E/CN.7/2021/8

Note by the Secretariat on the scope of control of substances: proposed scheduling recommendations by WHO

E/CN.7/2021/9- E/CN.15/2021/15 Note by the Secretariat on the draft programme plan for 2022 and programme performance for 2020

Conference Room Papers

E/CN.7/2021/CRP.1  

Chair’s summary on the thematic discussions on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration (19–21 October 2020)

E/CN.7/2021/CRP.2

Note by the Secretariat on the implementation of all international drug policy commitments, following-up to the 2019 Ministerial Declaration 

E/CN.7/2021/CRP.3

Note by the Secretariat on inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem

E/CN.7/2021/CRP.4

Strengthening international cooperation in combating illicit opiates originating in Afghanistan through continuous and reinforced support to the Paris Pact initiative 

E/CN.7/2021/CRP.5

Changes in the scope of control of substances: proposed 
scheduling recommendations by the World Health Organization 

E/CN.7/2021/CRP.6 

Conference Room Paper submitted jointly by Germany, Peru, Thailand and UNODC titled, “Opportunities and Challenges for the Role of Development in Drug Control Policies 

E/CN.7/2021/CRP.7

Reports by intergovernmental organizations on drug control activities

E/CN.7/2021/CRP.8

Conference Room Paper submitted by the Pompidou Group

E/CN.7/2021/CRP.9

List of documents before the Commission at its 64th session

NGO written statements

E/CN.7/2021/NGO/1  

Statement submitted by Turkish Green Crescent Society

E/CN.7/2021/NGO/2

Statement submitted by International Drug Policy Consortium (IDPC)

E/CN.7/2021/NGO/3

Statement submitted by Dianova International

E/CN.7/2021/NGO/4

Statement submitted by the Canadian HIV/AIDS Legal Network

E/CN.7/2021/NGO/5

Statement submitted by the Canadian Centre on Substance Abuse

E/CN.7/2021/NGO/6

Statement submitted by the European Coalition for Just and Effective Drug Policies (ENCOD)

Report

E/2021/28 - E/CN.7/2021/10  

Report on the 64th session of the Commission on Narcotic Drugs

 

 

Additional background papers

 Language

Title or description

Arabic

Chinese

English

French

Russian 

Spanish

Implementation of all international drug policy commitments:

- Ministerial Declaration on Strengthening Our Actions at the National, Regional and International Levels to Accelerate the Implementation of Our Joint Commitments to Address and Counter the World Drug Problem" (2019)

- Outcome document of the thirtieth special session of the General Assembly, entitled "Our joint commitment to effectively addressing and countering the world drug problem" (2016)

- Joint Ministerial Statement of the 2014 High-level Review by the Commission on Narcotic Drugs of the Implementation by Member States of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem (2014)

- Political Declaration and Plan of Action on International Cooperation towards and Integrated and Balanced Strategy to Counter the World Drug Problem (2009)